Sculptra vs Hyaluronic Acid Filler (Juvederm, Restylane)

Sort of.

Sculptra is injected like a filler and approved under the same FDA premarket-approval (PMA) route — Sculptra under PMA P030050, Juvéderm Voluma XC under PMA P110033 — but it is not a hyaluronic acid gel.

Sculptra is poly-L-lactic acid (PLLA), made by Galderma, and Galderma describes it as a "biostimulatory aesthetic injectable" that helps stimulate your body's own natural collagen production.

Its approval list is short.

Sculptra is indicated for correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles, for correction of fine lines and wrinkles in the cheek region — both in immune-competent people — and for restoration and/or correction of facial fat loss (lipoatrophy) in people with HIV.

It has no FDA indication for cheek volume, temples, jawline, chin, under-eyes, lips or the body, so those uses are off-label.

For the filler category as a whole, see dermal fillers.

Juvéderm and Restylane are crosslinked hyaluronic acid gels with lidocaine.

An HA gel adds volume where the injector places it: Allergan says Juvéderm results are visible immediately after treatment.

Sculptra is different.

Galderma says it works by stimulating your body's own collagen production, and the label builds that in: in Sculptra's trials, patients were treated to optimal correction at 3- or 4-week intervals, with a maximum of four sessions.

Right after a session the area looks fully corrected — but the label attributes that fullness to injection-related swelling, which resolves in several hours to a few days.

The original contour deficiency then reappears, and correction develops gradually over the following weeks.

The difference reaches the "what if I don't like it" question too. Hyaluronidase, the enzyme that breaks down hyaluronic acid, works only on HA fillers — Cleveland Clinic notes it does not dissolve other filler materials, so it does not dissolve Sculptra.

Radiesse, a calcium hydroxylapatite implant rather than an HA gel, is in the same position.

Dissolving even an HA filler is an off-label use of hyaluronidase, whose own labels list three approved clinical uses.

Juvéderm's safety information adds that the effectiveness of removing any dermal filler has not been studied.

With an HA gel, the gel is the volume, and Allergan says Juvéderm results are visible immediately after treatment.

Sculptra inverts that.

The label describes the appointment-day fullness as swelling that resolves in several hours to a few days, after which the original depression reappears and the treatment effect builds gradually over several weeks.

Galderma says results can be seen as early as 1 month after treatment.

The label also directs the provider to assess the need for more Sculptra only after at least four weeks, because the depression keeps improving as the treatment effect develops.

These are stated figures from the makers and the trials, not predictions for any one person, and individual timelines vary.

Durations are stated per product and per area, and every figure here is a manufacturer maximum, not an average.

Allergan's stated durations, all "with optimal treatment": Voluma XC cheeks up to 2 years, Voluma XC chin up to 1 year, Voluma XC temples up to 13 months, Volbella XC under-eyes up to 1 year, Volux XC jawline up to 1 year.

Galderma states Sculptra results are seen as early as 1 month and gives a duration of up to 2 years.

Merz states a duration of up to 2 years for Radiesse, a calcium hydroxylapatite implant, while Merz's own safety information says it is not known whether Radiesse is safe or effective beyond 3 years in the face.

Read all of these as upper bounds from each maker's own materials, not predictions.

Allergan's cheek figure and Galderma's Sculptra figure are both "up to 2 years", but they come from different companies, cover different products, and are not a like-for-like trial comparison of the two.

Allergan does not publish a price on its Juvéderm FAQ; it says pricing varies by the Juvéderm product, the amount used and the provider.

The broadest national figures come from the American Society of Plastic Surgeons (ASPS), which lists average costs of $715 for hyaluronic acid fillers, $901 for non-HA fillers (such as Radiesse and Sculptra) and $743 for lip augmentation with filler, per its latest statistics.

Those are national average physician fees — not med spa prices and not per-syringe quotes for any product.

What a practice near you charges is a question for the practice.

Sculptra adds a structural difference: the treatment itself is a course.

The trials ran to as many as four sessions at 3- or 4-week intervals, and the label says the need for further sessions is assessed only after at least four weeks — so a total depends on how many sessions your provider recommends.

One overlap worth knowing: Restylane and Sculptra are both Galderma products, and the maker's ASPIRE Galderma Rewards program earns points on qualifying treatments with both.

Juvéderm and Restylane are families of HA gels, with a separate approval for each product and area.

Juvéderm Voluma XC is FDA-approved for deep injection for cheek augmentation to correct age-related midface volume deficit (2013), for chin augmentation (2020) and for temple hollowing (2023), in adults over 21.

Restylane was first approved in 2005 for moderate to severe facial wrinkles and folds such as nasolabial folds and added a lip indication in 2011.

Restylane Lyft is approved for folds, the cheeks, the back of the hands and the chin; Restylane Contour for the cheeks and, since 2026, temple hollowing; Restylane Kysse for the lips and upper perioral lines.

Sculptra's list is shorter and worded differently: nasolabial fold contour deficiencies and other facial wrinkles, fine lines and wrinkles in the cheek region, and HIV facial fat loss.

The cheek entry trips people up.

Approved in 2023, it covers fine lines and wrinkles in the cheek region — not cheek volume or augmentation, the indication Voluma XC, Restylane Lyft and Restylane Contour hold.

The same gap runs through the other named areas.

Sculptra has no lip indication, where Restylane Kysse does.

It has no jawline indication either — the only fillers with approved jawline uses are Juvéderm Volux XC (2022) and Radiesse (+) (2021).

Galderma's own site cites 86% improved jawline contour at 2 years from a study that ended at 96 weeks — a marketing claim about a use that is not on Sculptra's label, not an indication.

So a search like "Sculptra vs Voluma" is really a choice between two different tools aimed at the same region: a gel approved to augment cheek volume, and a poly-L-lactic acid injectable approved for fine lines and wrinkles in that region.

Match the approved use to your goal, and let a licensed provider examine the area before deciding which products' labels fit it.

The labels draw the decision lines; they don't pick a winner.

• Speed. Allergan says Juvéderm results are visible immediately; Sculptra's correction builds over weeks, across a series of up to four sessions.
• Match the indication. Cheek volume has dedicated HA approvals — Voluma XC, Restylane Lyft, Restylane Contour — while Sculptra's cheek approval covers fine lines and wrinkles only. For smile lines, both categories hold approvals.
• Adjustability. An HA gel can be broken down with hyaluronidase (an off-label use); Sculptra cannot.
• Course length. Sculptra appointments sat 3 or 4 weeks apart in the trials, with progress assessed after at least four weeks.

Which line matters most depends on your anatomy, the area and your timeline — things no article can see.

A licensed provider can map the area, confirm which products are approved for it, and set the schedule the labels describe.

If Sculptra is on your short list, the Sculptra guide goes deeper on the label, sessions and cost.